Asia Pacific Bioreactors Market growth was valued at USD 764.3 million in 2019 and is expected to witness over 15.6% CAGR from 2020 to 2026.
Bioreactors or fermentors are vessels wherein chemical processes are carried out using organisms or biochemically active substances. They are widely used in the areas of biopharmaceuticals, vaccines, and research and development of various novel entities.
Get more details on this report - Request Free Sample PDF
Innovations in single-use bioreactors will offer momentous growth opportunities to Asia Pacific bioreactors market. Advances in bioreactors have presented standardization and automation in bioprocessing along with advantages related to time. These advancements include continuous manufacturing, remote monitoring of culture process, integration of analytical technology, and single-use systems. Additionally, single-use bioreactors are cost-effective that further increases their preference among customers.
Asia Pacific Market, By Product Type
Bioreactors market is segmented as single-use bioreactors and reusable bioreactors based on product type. Reusable bioreactors segment held over 75% revenue share in 2019. Reusable bioreactors assist in the production of drugs and vaccines at larger volume and scale. Since there are numerous pharmaceuticals and biologics manufacturers along with contract manufacturing organizations in countries such as China and India, the segment will foresee robust growth.
Asia Pacific Market, By Cell
Bioreactors market is segmented on the basis of cell as mammalian cells, bacterial cells, yeast cells and others. Mammalian cells segment held over USD 590 million revenue size in 2019. Mammalian cells have wide adoption as they have use in bioprocessing of viral vaccines, therapeutics and diagnostic proteins. They are also used for research purposes. Thus, increasing adoption of mammalian cells coupled with growing vaccines and biologics industry will in turn boost the segmental growth over the analysis period.
Asia Pacific Market, By Molecule
Based on molecule, bioreactors market is segmented as monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy and others. Stem cells segment is forecasted to proceed at more than 16.5% CAGR. Rising number of research activities to develop stem cell therapy for a wide range of applications including regenerative medicine and aesthetic medicine will increase the segment growth. In addition, increasing focus and investment by firms for R&D in this space will further influence segmental size expansion.
Asia Pacific Market, By End-user
On the basis of end-users, bioreactors market is segmented as R&D organizations, biopharmaceutical manufacturers, contract manufacturing organizations (CMOs). Adoption of bioreactors in contract manufacturing organizations will expand during the analysis period. Numerous companies based in the developed countries outsource manufacturing activities to Asian countries owing to cost advantage. Thus, with growing need for cost containment and hence, increasing number of CMOs in the region, the demand for bioreactors will increase in the forthcoming years.
Asia Pacific Market, By Country
India bioreactors market held over 17% market share in 2019. Presence of major market players in the country will serve to be high impacting factor for market growth. Presence of market players positively impact product availability and supply. In addition, there are several biopharmaceutical companies and CMOs, that will further create demand for bioreactors in the nation in the forecast timeframe.
Competitive Market Share
Some of the major industry players involved in Asia Pacific bioreactors market include Sartorius Stedim Biotech, Cytiva, Merck, Thermo Fisher Scientific, and Eppendorf AG among others. Market players are undertaking various strategies such as collaborations, and product launch to strengthen their market position. For instance, in November 2019, Applikon Biotechnology introduced 3L single-use bioreactor for lab-scale production expanding its AppliFlex ST Family of single-use bioreactors. This product portfolio expansion has boosted firm’s revenue, thus strengthening company’s footprint in the market.
Bioreactors or fermentors were used for production of chemicals, specialized molecules, probiotics among several other substances. Stainless steel bioreactors were used widely for mass production of various end products. With high cost being associated with reusable bioreactors, single-use bioreactors were developed. These bioreactors offer effective and affordable option to reusable bioreactors. With growing research and development and budget constraints, these systems are being widely adopted. Thus, Asia Pacific market will witness rapid demand for advanced bioreactors with expanding pharma industry and entry of numerous lifesciences firms in the foreseeable future.